New Proton Pump Inhibitors – Crystalline Patent Abeprazan Succinate (DWP14012) – Granted to Korean Firm Daewoong
Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+– ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is…